Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein.
暂无分享,去创建一个
Xiangyu Zhang | Yongchao Liu | Lu Yin | Chunqiu Chen | Xiangyu Zhang | Sheng Wang | Yongchao Liu | Chunqiu Chen | Lu Yin | Sheng Wang
[1] Yun Wang,et al. Long Noncoding RNA GAS5 Suppresses Tumorigenesis by Inhibiting miR-23a Expression in Non-Small Cell Lung Cancer , 2017, Oncology research.
[2] Gang Ma,et al. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. , 2018, Clinics and research in hepatology and gastroenterology.
[3] C. Kong,et al. Loss of P53 facilitates invasion and metastasis of prostate cancer cells , 2013, Molecular and Cellular Biochemistry.
[4] Yang Wang,et al. LncRNA GAS5 Represses Osteosarcoma Cells Growth and Metastasis via Sponging MiR-203a , 2018, Cellular Physiology and Biochemistry.
[5] Yvonne Tay,et al. Noncoding RNA:RNA Regulatory Networks in Cancer , 2018, International journal of molecular sciences.
[6] A. Jemal,et al. Global Cancer Statistics , 2011 .
[7] Junming Guo,et al. Roles of long noncoding RNAs in gastric cancer and their clinical applications , 2016, Journal of Cancer Research and Clinical Oncology.
[8] David Piwnica-Worms,et al. Contribution of p53 to metastasis. , 2014, Cancer discovery.
[9] C. Ponting,et al. Evolution and Functions of Long Noncoding RNAs , 2009, Cell.
[10] Qiwen Ben,et al. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer , 2018, Cell Death & Disease.
[11] Gwyn T. Williams,et al. Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA , 2015, Genes.
[12] Jun Ma,et al. lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer , 2018, Molecular therapy. Nucleic acids.
[13] Hong Lu,et al. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway , 2017, Digestive Diseases and Sciences.
[14] L. Attardi,et al. Deconstructing networks of p53-mediated tumor suppression in vivo. , 2018 .
[15] F. Ciardiello,et al. Treatment of gastric cancer. , 2014, World journal of gastroenterology.
[16] G. Chrousos,et al. Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor , 2010, Science Signaling.
[17] Fenghua Wang,et al. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression , 2016, Journal of Experimental & Clinical Cancer Research.
[18] Juan Liu,et al. Tumor suppressor p53 and its gain-of-function mutants in cancer. , 2014, Acta biochimica et biophysica Sinica.
[19] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[20] Thomas Kirchner,et al. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. , 2014, Cancer research.
[21] Ming Sun,et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer , 2014, BMC Cancer.
[22] X. Dang,et al. Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis , 2017, Cell & Bioscience.
[23] Yufeng Du,et al. Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway , 2018, Oncology letters.
[24] Marcel W. Coolen,et al. Regulatory Roles for Long ncRNA and mRNA , 2013, Cancers.
[25] Huimin Guo,et al. The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer. , 2018, Journal of gastrointestinal and liver diseases : JGLD.
[26] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.
[27] Ping Chen,et al. Long noncoding RNAs in gastric cancer: functions and clinical applications , 2016, OncoTargets and therapy.
[28] C. Klinge. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. , 2018, Endocrine-related cancer.
[29] Howard Y. Chang,et al. Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.
[30] H. Dai,et al. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells , 2015, Journal of Biomedical Science.
[31] Shan Wang,et al. Long non-coding RNA GAS5 inhibits cell proliferation, induces G0/G1 arrest and apoptosis, and functions as a prognostic marker in colorectal cancer. , 2017, Oncology letters.
[32] Wei Gao,et al. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[33] Nanjiang Zhou,et al. Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line , 2017, Cell Death & Disease.
[34] J. Zhao,et al. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer , 2015, Scientific Reports.
[35] Jianchun Yu,et al. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. , 2015, World journal of gastroenterology.
[36] H. Yao,et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. , 2015, Cancer cell.
[37] J. Bok,et al. Identification of evidence for autoimmune pathology of bilateral sudden sensorineural hearing loss using proteomic analysis. , 2017, Clinical immunology.